Watanabe, A., Ishizuka, T., Yamada, M., Igawa, Y., Shimizu, T., & Ishizuka, H. (2022). Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment. European journal of clinical pharmacology, 78(1), 75. https://doi.org/10.1007/s00228-021-03211-z
Chicago Style (17th ed.) CitationWatanabe, Akiko, Tomoko Ishizuka, Makiko Yamada, Yoshiyuki Igawa, Takako Shimizu, and Hitoshi Ishizuka. "Correction to: Physiologically Based Pharmacokinetic Modelling to Predict the Clinical Effect of CYP3A Inhibitors/inducers on Esaxerenone Pharmacokinetics in Healthy Subjects and Subjects with Hepatic Impairment." European Journal of Clinical Pharmacology 78, no. 1 (2022): 75. https://doi.org/10.1007/s00228-021-03211-z.
MLA (9th ed.) CitationWatanabe, Akiko, et al. "Correction to: Physiologically Based Pharmacokinetic Modelling to Predict the Clinical Effect of CYP3A Inhibitors/inducers on Esaxerenone Pharmacokinetics in Healthy Subjects and Subjects with Hepatic Impairment." European Journal of Clinical Pharmacology, vol. 78, no. 1, 2022, p. 75, https://doi.org/10.1007/s00228-021-03211-z.